Using UVC to enhance dental implant stability
Effect of Photofunctionalization With on Titanium Dental Implants. A Pilot Sutdy
NA · Universidad Complutense de Madrid · NCT06724107
This study tests if using UVC light on dental implants can help them bond better with the bone and allow for quicker use after surgery.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Universidad Complutense de Madrid (other) |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Madrid) |
| Trial ID | NCT06724107 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of a photofunctionalization technique using ultraviolet C (UVC) radiation on dental implants. The study will compare standard implants with those treated with UVC to determine if this method accelerates bone apposition and increases the amount of bone binding to the implant. It is a randomized, controlled, single-center pilot study involving patients requiring dental implant surgery. The goal is to potentially allow for quicker loading of the implants after placement.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 years old who need dental implant surgery, with or without additional bone or soft tissue procedures.
Not a fit: Patients with systemic diseases affecting coagulation, active infections, or those undergoing specific pharmacological treatments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to faster recovery times and improved outcomes for patients receiving dental implants.
How similar studies have performed: While the use of UVC in dental applications is relatively novel, preliminary studies suggest potential benefits, but further validation is needed.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 18 years of age. * Patients requiring dental implant surgery with or without bone or soft tissue regeneration surgery. * Acceptance of the informed consent document. Exclusion Criteria: * Subjects with systemic diseases leading to untreated or uncontrolled haemostasis or coagulation disturbances. * Subjects with active infectious diseases (tuberculosis, HIV, syphilis, hepatitis, etc). * Patients under pharmacological treatment with monoclonal antibodies, bisphosphonates, chemotherapy or prolonged treatment with corticoids. * Patients with alcoholism or drug addiction. * Pregnant or breastfeeding women.
Where this trial is running
Madrid
- Jesus Torres — Madrid, Spain (RECRUITING)
Study contacts
- Study coordinator: jesus gd torres, PhD
- Email: jesus.torres@ucm.es
- Phone: +34653050071
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Implant Site Reaction, ISQ, inmediate loading, UVC, dental implants